BDX vs TEM · P/E 34, rev $21.84B vs rev $1.27B
Becton Dickinson and Company (BDX) versus Tempus AI, Inc. Class A Common Stock (TEM) — a side-by-side from cached financials, not a winner call.
Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.
Tempus AI, Inc. Class A Common Stock (TEM) is a health information services company listed on NASDAQ.
Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. Revenue was up 8.2% from 2024-09-30 to 2025-09-30. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
Latest reported TEM revenue for 2025-12-31 was $1.27B. Net income was -$245.0M. Revenue was up 83.4% from 2024-12-31 to 2025-12-31. TEM currently screens at market cap $8.76B.
BDX currently screens at market cap $50.30B and trailing P/E 33.9. TEM currently screens at market cap $8.76B.
Not investment advice. Open the BDX and TEM stock pages for the full models.
Not investment advice.